SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biocept Inc. – ‘S-1/A’ on 5/16/23 – ‘EX-23.2’

On:  Tuesday, 5/16/23, at 4:11pm ET   ·   Accession #:  1193125-23-146104   ·   File #:  333-271355

Previous ‘S-1’:  ‘S-1/A’ on 5/15/23   ·   Next:  ‘S-1/A’ on 5/19/23   ·   Latest:  ‘S-1/A’ on 5/23/23   ·   37 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/16/23  Biocept Inc.                      S-1/A                  6:451K                                   Donnelley … Solutions/FA

Pre-Effective Amendment to Registration Statement (General Form)   —   Form S-1   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Pre-Effective Amendment to Registration Statement   HTML    259K 
                (General Form)                                                   
 2: EX-4.13     Instrument Defining the Rights of Security Holders  HTML     95K 
 3: EX-5.1      Opinion of Counsel re: Legality                     HTML     14K 
 4: EX-23.1     Consent of Expert or Counsel                        HTML      5K 
 5: EX-23.2     Consent of Expert or Counsel                        HTML      5K 
 6: EX-FILING FEES  Filing Fees                                     HTML     33K 


‘EX-23.2’   —   Consent of Expert or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-23.2  

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in this Amendment No. 2 to the Registration Statement (No. 333-271355) on Form S-1 and related Prospectus of Biocept, Inc. of our report dated April 17, 2023 relating to the financial statements of Biocept, Inc., appearing in the Annual Report on Form 10-K of Biocept, Inc. for the year ended December 31, 2022.

We also consent to the reference to our firm under the heading “Experts” in such Prospectus.

/s/ RSM US LLP

Dallas, Texas

May 16, 2023


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-1/A’ Filing    Date    Other Filings
Filed on:5/16/238-K
4/17/2310-K,  10-Q/A,  8-K
12/31/2210-K,  NT 10-K
 List all Filings 


37 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/16/23  Biocept Inc.                      8-K:3,9     5/16/23   11:151K                                   Donnelley … Solutions/FA
 5/15/23  Biocept Inc.                      S-1/A                  8:709K                                   Donnelley … Solutions/FA
 5/15/23  Biocept Inc.                      8-K:2,3,5,9 5/10/23   11:220K                                   Donnelley … Solutions/FA
 5/10/23  Biocept Inc.                      10-Q        3/31/23   58:6.8M                                   Donnelley … Solutions/FA
 4/21/23  Biocept Inc.                      DEFR14A                1:211K                                   Donnelley … Solutions/FA
 4/20/23  Biocept Inc.                      S-1                    4:345K                                   Donnelley … Solutions/FA
 4/20/23  Biocept Inc.                      DEF 14A     5/11/23    1:211K                                   Donnelley … Solutions/FA
 4/17/23  Biocept Inc.                      8-K:4       4/14/23   10:139K                                   Donnelley … Solutions/FA
 4/17/23  Biocept Inc.                      10-K       12/31/22   72:11M                                    Donnelley … Solutions/FA
 4/17/23  Biocept Inc.                      10-Q/A      9/30/22   66:12M                                    Donnelley … Solutions/FA
 4/10/23  Biocept Inc.                      8-K:1,3,5,9 4/10/23   12:214K                                   Donnelley … Solutions/FA
 3/20/23  Biocept Inc.                      8-K:5       3/16/23   10:133K                                   Donnelley … Solutions/FA
 1/06/23  Biocept Inc.                      8-K:2,8,9   1/06/23   11:164K                                   Donnelley … Solutions/FA
11/10/22  Biocept Inc.                      10-Q        6/30/22   62:7.7M                                   ActiveDisclosure/FA
 4/05/22  Biocept Inc.                      10-K       12/31/21   88:13M                                    ActiveDisclosure/FA
 3/24/22  Biocept Inc.                      8-K:5,9     3/22/22   11:148K                                   Donnelley … Solutions/FA
 3/08/22  Biocept Inc.                      8-K:5,9     3/08/22   11:214K                                   Donnelley … Solutions/FA
 2/16/22  Biocept Inc.                      8-K:5,9     2/15/22   12:289K                                   Donnelley … Solutions/FA
 9/04/20  Biocept Inc.                      8-K:3,5,9   9/03/20    2:62K                                    ActiveDisclosure/FA
 8/13/20  Biocept Inc.                      10-Q        6/30/20   72:9.3M                                   ActiveDisclosure/FA
 1/09/20  Biocept Inc.                      8-K:1,3,9   1/09/20    3:284K                                   ActiveDisclosure/FA
12/11/19  Biocept Inc.                      8-K:8,9    12/09/19    4:290K                                   ActiveDisclosure/FA
 5/29/19  Biocept Inc.                      8-K:1,3,9   5/28/19    3:273K                                   ActiveDisclosure/FA
 3/18/19  Biocept Inc.                      8-K:1,3,8,9 3/15/19    6:670K                                   ActiveDisclosure/FA
11/28/18  Biocept Inc.                      S-1                    4:827K                                   ActiveDisclosure/FA
 9/24/18  Biocept Inc.                      8-K:1,3,8,9 9/20/18    7:830K                                   ActiveDisclosure/FA
 8/13/18  Biocept Inc.                      8-K:3,5,8,9 8/09/18    3:463K                                   ActiveDisclosure/FA
 7/11/18  Biocept Inc.                      S-1/A                 15:3.6M                                   Donnelley … Solutions/FA
 7/06/18  Biocept Inc.                      8-K:3,5,9   7/06/18    2:57K                                    ActiveDisclosure/FA
 9/29/17  Biocept Inc.                      8-K:5,9     9/27/17    2:49K                                    ActiveDisclosure/FA
 9/29/16  Biocept Inc.                      8-K:5,8,9   9/27/16    3:319K                                   ActiveDisclosure/FA
 8/08/14  Biocept Inc.                      10-Q        6/30/14   55:3.6M                                   Donnelley … Solutions/FA
 5/06/14  Biocept Inc.                      8-K:1,2,3,9 4/30/14    3:366K                                   Donnelley … Solutions/FA
 2/14/14  Biocept Inc.                      8-K:1,3,5,8 2/10/14    3:368K                                   Donnelley … Solutions/FA
 1/30/14  Biocept Inc.                      S-1/A                  3:475K                                   Donnelley … Solutions/FA
 1/28/14  Biocept Inc.                      8-A12B                 1:13K                                    Donnelley … Solutions/FA
 9/23/13  Biocept Inc.                      S-1¶                  71:6.2M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001193125-23-146104   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 2:15:03.3am ET